- On Announcement of All Oral MDR TB regimen by Indian Government
- Modi visit to US: Trump appearance signals importance of India
- After ‘Howdy Modi’, Trump and Modi likely to sign trade deal
- US – India Relations: President Trump To Sign New Trade Deal With Indian PM Modi?
- India-US trade talks: Trading lives?
Category Archives: Regulation
Source: live mint | April 25, 2018 New Delhi: Government think tank NITI Aayog, in a note on free trade agreements (FTAs) and their costs for India, has argued that the country needs to rethink joining the Regional Comprehensive Economic Partnership … Continue reading
Breaking news for access to biological medicines – Brazilian court nixes biological drug eculizumab patent, says more could follow
Source: BioCentury | April 21, 2018 A Brazilian court unanimously ruled Friday to remove patent protection for Soliris eculizumab from Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), opening the door for production of biosimilar versions in the country. In a statement, Brazil’s Attorney General Office said … Continue reading
By Simon Gottwalt. The recent price hike of Daraprim, a 62 year old medicine used against toxoplasmosis, created a massive public outcry against Turing Pharmaceuticals, who had just acquired the drug, and its CEO Martin Shkreli, making him “the most hated man in … Continue reading
Source: The Wall Street Journal 20 March 2015 In yet another fracas over Gilead Sciences and its hepatitis C treatments, Doctors Without Borders is harshly criticizing the drug maker over an agreement in which several generic companies will sell lower-cost … Continue reading
Source: The Lancet India has strongly objected to the findings of new research that raises questions about the quality of drugs manufactured in the country and exported abroad. Sanjeet Bagcchi reports. Findings from a new investigation have raised questions over … Continue reading